Healthcare sector news highlights include Novo Nordisk rebranding to 'Novo' to compete with Eli Lilly in the obesity market. Summit Therapeutics reported ivonescimab reduced lung cancer death risk by 27% versus Keytruda. GE HealthCare is nearing a $1B acquisition of Sofie Biosciences. Eli Lilly received full FDA approval for its Inluriyo combo in breast cancer, while Medtronic launched an exchange offer to separate its MiniMed diabetes business.